Cyclovirobuxine D
CAS: 860-79-7
Ref. 3D-FC66624
25mg | 136,00 € | ||
50mg | 147,00 € | ||
100mg | 205,00 € | ||
250mg | 366,00 € | ||
500mg | 502,00 € |
Produktinformation
- (3beta,5alpha,9beta,16alpha,20S)-4,4,14-trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol
- (3beta,5alpha,9xi,10xi,14xi,16alpha,20S)-4,4,14-trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol
- (3α,5α,16α,20S)-4,4,14-Trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol
- (3β,5α,16α,20S)-4,4,14-Trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol
- 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, 9,19-cyclopregnan-16-ol deriv.
- 9,19-Cyclo-5α,9β-pregnan-16α-ol, 4,4,14-trimethyl-3β,20α-bis(methylamino)-
- 9,19-Cyclopregnan-16-ol, 4,4,14-trimethyl-3,20-bis(methylamino)-, (3β,5α,16α,20S)-
- Bebuxine
- Cvb-D
- Cyclovirobuxin D
- Mehr Synonyme anzeigen
- Cyclovirobuxine
- Cyclovirobuxinum D
- NSC 91722
Cyclovirobuxine D is a natural product that has been isolated from the stem bark of a Malaysian tree. It has shown synergistic effects with other compounds, such as cyclovirobuxine, in enhancing axonal growth and energy metabolism. Cyclovirobuxine D has also been shown to have a synergistic effect with cyclase inhibitors, such as rolipram and rolofylline, in the prevention of myocardial infarct. It blocks the cytosolic Ca2+ channel by binding to the ryanodine receptor and inhibiting Ca2+ release. The drug also inhibits glucose uptake in epithelial cells, which leads to cell death by apoptosis. Cyclovirobuxine D can be detected using analytical methods such as high-performance liquid chromatography (HPLC) or preparative HPLC.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FC66624 Cyclovirobuxine D
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.